Julio A. Peguero

Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial

Hope S. Rugo, Lasika Seneviratne, J. Thaddeus Beck et al. · The Lancet Oncology · 2017 · 225 citations

Medicine, Endocrinology, Oncology +17

Efficacy and Safety of Adagrasib plus Cetuximab in Patients with <i>KRAS</i> G12C-Mutated Metastatic Colorectal Cancer

Rona Yaeger, Nataliya V. Uboha, Meredith S. Pelster et al. · Cancer Discovery · 2024 · 117 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer

Ryan J. Hartmaier, Sally E. Trabucco, Nolan Priedigkeit et al. · Annals of Oncology · 2018 · 108 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Development of 2 Bromodomain and Extraterminal Inhibitors With Distinct Pharmacokinetic and Pharmacodynamic Profiles for the Treatment of Advanced Malignancies

Gerald S. Falchook, Seth Rosen, Patricia LoRusso et al. · Clinical Cancer Research · 2019 · 79 citations

Medicine, Oncology, Pharmacology +10

Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2− breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2

Senthil Damodaran, Ciara C. O’Sullivan, Ahmed Elkhanany et al. · Annals of Oncology · 2023 · 54 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17